0001209191-23-052206.txt : 20231005
0001209191-23-052206.hdr.sgml : 20231005
20231005163409
ACCESSION NUMBER: 0001209191-23-052206
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231004
FILED AS OF DATE: 20231005
DATE AS OF CHANGE: 20231005
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Luthringer Remy
CENTRAL INDEX KEY: 0001610384
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36517
FILM NUMBER: 231311791
MAIL ADDRESS:
STREET 1: C/O MINERVA NEUROSCIENCES, INC.
STREET 2: 1601 TRAPELO ROAD, SUITE 286
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Minerva Neurosciences, Inc.
CENTRAL INDEX KEY: 0001598646
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 260784194
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1601 TRAPELO ROAD
STREET 2: SUITE 286
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-600-7373
MAIL ADDRESS:
STREET 1: 1601 TRAPELO ROAD
STREET 2: SUITE 286
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-10-04
0
0001598646
Minerva Neurosciences, Inc.
NERV
0001610384
Luthringer Remy
C/O MINERVA NEUROSCIENCES, INC.
1500 DISTRICT AVENUE
BURLINGTON
MA
01803
1
1
0
0
CEO
0
Employee Stock Option (right to buy)
6.41
2023-10-04
4
A
0
100450
0.00
A
2033-10-03
Common Stock
100450
100450
D
The option vests 25% on October 4, 2024 and then in equal quarterly installments over 3 years thereafter.
/s/ Ryan Sansom, Attorney-in-Fact
2023-10-05